Annual long term liabilities:
$442.29M-$7.73M(-1.72%)Summary
- As of today (May 24, 2025), FOLD annual total long term liabilities is $442.29 million, with the most recent change of -$7.73 million (-1.72%) on December 31, 2024.
- During the last 3 years, FOLD annual long term liabilities has fallen by -$9.51 million (-2.10%).
- FOLD annual long term liabilities is now -21.82% below its all-time high of $565.74 million, reached on December 30, 2016.
Performance
FOLD Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$443.39M+$1.10M(+0.25%)Summary
- As of today (May 24, 2025), FOLD quarterly total long term liabilities is $443.39 million, with the most recent change of +$1.10 million (+0.25%) on March 31, 2025.
- Over the past year, FOLD quarterly long term liabilities has dropped by -$5.60 million (-1.25%).
- FOLD quarterly long term liabilities is now -22.62% below its all-time high of $573.01 million, reached on March 31, 2017.
Performance
FOLD quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FOLD Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -1.3% |
| 3 y3 years | -2.1% | -3.3% |
| 5 y5 years | +80.5% | +81.7% |
FOLD Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | at low | -4.1% | +0.3% |
| 5 y | 5-year | -6.0% | +80.5% | -5.8% | +91.0% |
| alltime | all time | -21.8% | >+9999.0% | -22.6% | >+9999.0% |
FOLD Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $443.39M(+0.2%) |
| Dec 2024 | $442.29M(-1.7%) | $442.29M(-1.6%) |
| Sep 2024 | - | $449.59M(+0.2%) |
| Jun 2024 | - | $448.89M(-0.0%) |
| Mar 2024 | - | $448.99M(-0.2%) |
| Dec 2023 | $450.02M(-2.6%) | $450.02M(-2.5%) |
| Sep 2023 | - | $461.39M(+0.5%) |
| Jun 2023 | - | $459.28M(-0.1%) |
| Mar 2023 | - | $459.56M(-0.5%) |
| Dec 2022 | $462.10M(+2.3%) | $462.10M(-0.0%) |
| Sep 2022 | - | $462.31M(-0.0%) |
| Jun 2022 | - | $462.54M(+0.9%) |
| Mar 2022 | - | $458.62M(+1.5%) |
| Dec 2021 | $451.80M(-4.0%) | $451.80M(-1.6%) |
| Sep 2021 | - | $458.94M(-0.4%) |
| Jun 2021 | - | $460.99M(+0.3%) |
| Mar 2021 | - | $459.49M(-2.3%) |
| Dec 2020 | $470.46M(+92.0%) | $470.46M(+0.4%) |
| Sep 2020 | - | $468.55M(+101.8%) |
| Jun 2020 | - | $232.20M(-4.9%) |
| Mar 2020 | - | $244.04M(-0.4%) |
| Dec 2019 | $244.97M(-32.1%) | $244.97M(+1.7%) |
| Sep 2019 | - | $240.94M(+5.5%) |
| Jun 2019 | - | $228.43M(-7.6%) |
| Mar 2019 | - | $247.16M(-31.5%) |
| Dec 2018 | $360.91M(+76.8%) | $360.91M(-0.2%) |
| Sep 2018 | - | $361.76M(+71.4%) |
| Jun 2018 | - | $211.03M(+1.6%) |
| Mar 2018 | - | $207.68M(+1.7%) |
| Dec 2017 | $204.13M(-63.9%) | $204.13M(+0.6%) |
| Sep 2017 | - | $202.94M(-64.5%) |
| Jun 2017 | - | $571.39M(-0.3%) |
| Mar 2017 | - | $573.01M(+1.3%) |
| Dec 2016 | $565.74M(+16.2%) | $565.74M(+14.1%) |
| Sep 2016 | - | $496.01M(-0.7%) |
| Jun 2016 | - | $499.30M(+2.6%) |
| Mar 2016 | - | $486.85M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $486.93M(+620.3%) | $486.93M(-14.9%) |
| Sep 2015 | - | $572.07M(+884.5%) |
| Jun 2015 | - | $58.11M(-14.0%) |
| Mar 2015 | - | $67.58M(-0.0%) |
| Dec 2014 | $67.60M(-5.3%) | $67.60M(-1.1%) |
| Sep 2014 | - | $68.39M(-3.0%) |
| Jun 2014 | - | $70.52M(-1.9%) |
| Mar 2014 | - | $71.91M(+0.8%) |
| Dec 2013 | $71.35M(+125.6%) | $71.35M(+109.7%) |
| Sep 2013 | - | $34.02M(+3.7%) |
| Jun 2013 | - | $32.81M(+2.9%) |
| Mar 2013 | - | $31.88M(+0.8%) |
| Dec 2012 | $31.63M(+51.0%) | $31.63M(+0.3%) |
| Sep 2012 | - | $31.52M(+52.9%) |
| Jun 2012 | - | $20.62M(-7.4%) |
| Mar 2012 | - | $22.26M(+6.3%) |
| Dec 2011 | $20.95M(-33.3%) | $20.95M(-10.7%) |
| Sep 2011 | - | $23.45M(-18.6%) |
| Jun 2011 | - | $28.80M(-12.3%) |
| Mar 2011 | - | $32.85M(+4.6%) |
| Dec 2010 | $31.39M(+1239.4%) | $31.39M(+512.8%) |
| Sep 2010 | - | $5.12M(+51.7%) |
| Jun 2010 | - | $3.38M(-33.8%) |
| Mar 2010 | - | $5.11M(+117.8%) |
| Dec 2009 | $2.34M(-94.7%) | $2.34M(-94.8%) |
| Sep 2009 | - | $44.65M(-0.3%) |
| Jun 2009 | - | $44.80M(+2.8%) |
| Mar 2009 | - | $43.56M(-1.8%) |
| Dec 2008 | $44.35M(-7.6%) | $44.35M(-1.9%) |
| Sep 2008 | - | $45.21M(-2.0%) |
| Jun 2008 | - | $46.12M(-2.0%) |
| Mar 2008 | - | $47.04M(-2.0%) |
| Dec 2007 | $48.01M(-62.2%) | $48.01M(+2951.9%) |
| Sep 2007 | - | $1.57M(-19.5%) |
| Jun 2007 | - | $1.95M(-98.7%) |
| Mar 2007 | - | $150.76M(+18.8%) |
| Dec 2006 | $126.95M(+105.1%) | $126.95M(+105.1%) |
| Dec 2005 | $61.91M | $61.91M |
FAQ
- What is Amicus Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics annual long term liabilities year-on-year change?
- What is Amicus Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly long term liabilities year-on-year change?
What is Amicus Therapeutics annual total long term liabilities?
The current annual long term liabilities of FOLD is $442.29M
What is the all time high annual long term liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total long term liabilities is $565.74M
What is Amicus Therapeutics annual long term liabilities year-on-year change?
Over the past year, FOLD annual total long term liabilities has changed by -$7.73M (-1.72%)
What is Amicus Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FOLD is $443.39M
What is the all time high quarterly long term liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total long term liabilities is $573.01M
What is Amicus Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FOLD quarterly total long term liabilities has changed by -$5.60M (-1.25%)